12th Annual Symposium on
Magnetic Resonance in Radiation Therapy

Status, Challenges & Opportunities

June 17-19 2026, Odense, Denmark

Endorsed by

MRinRT 2026

MRinRT 2026 is a three-day, single-track international symposium dedicated to advancing the integration of magnetic resonance imaging (MRI) in radiotherapy. The meeting will take place in Odense, Denmark, bringing together researchers, radiotherapy professionals, and industry partners to share the latest developments, challenges, and future directions in MRI-guided and MRI-informed radiotherapy. The symposium will feature a focused programme of invited lectures, proffered papers, poster-pitch and poster viewing, young investigator award and panel discussions, highlighting both clinical implementation and cutting-edge research in areas such as adaptive MRI-guided radiotherapy, quantitative and functional MRI, AI-driven workflows, and biological image guidance. This year, the International Society for Magnetic Resonance in Medicine (ISMRM) has been invited to join the scientific committee and has contributed to the development of the programme to foster collaboration between the radiotherapy and MRI communities. MRinRT 2026 aims to accelerate translation of MRI innovations into clinical practice, ultimately improving precision, personalization, and outcomes in cancer treatment.

When

June 17 - 19, 2026

Where

Comwell H.C. Andersen
Claus Bergs Gade 9
Odense 5000, Denmark

Deadlines

  • Abstract Submission:  January 22, 2026
  • Registration Closing:  April 30, 2026

Program

Wednesday, 17th of June

  • Uulke van der Heide
    Netherlands Cancer Institute, Amsterdam, The Netherlands

Moderator(s): TBD
  • Offline MRI-guided RT
    Neelam Tyagi
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
  • Online MRI-guided RT
    Sebastian Klüter
    Heidelberg University Hospital, Heidelberg, Germany
Proffered papers:
Time Title Name Abstract
10:50 Teaching an old dog new tricks: developing customized RF coils for radiation therapy MR simulation — considerations and experiences. Kiaran McGee 27
11:00 Metal artifact reduction for 3T MRI-only prostate radiotherapy with hip prostheses: target definition, synthetic CT and fiducial marker identification Mizgin Coskun 36
11:10 Treating intermediate-risk prostate cancer with no prior patient-specific imaging using online adaptive MRI-guided radiotherapy Søren Agergaard 91
11:20 Automation enables efficient MRI-enhanced online adaptive RT on a conventional C-arm linac Hubert Gabrys 87

Moderator: TBD
Time Title Name Abstract
11:45 Plan quality reporting for single-fraction, stereotactic MR-guided adaptive radiotherapy Kathryn Mittauer 70
11:55 Treatment efficiency and dosimetric benefit of intrafraction motion management during MRI-guided SBRT for liver tumors Thomas Willigenburg 6
12:05 MRI Toolkit for 0.35 T MR-Linac Adaptive Workflows: Toward Robust Quantitative Biomarkers for dose painting Matteo Nardini 69
12:15 Target-driven acquisition and super-resolution reconstruction for simultaneous cine imaging and 4D-MRI Nikolai Mickevicius 100
12:25 Deformable Dose Accumulation Variability Analysis in Localized Pancreatic Cancer Treated with MR-Guided Adaptive Radiotherapy Nicolas Cote 95
12:35 Motion management application in two-fraction prostate radiotherapy: initial DESTINATION 2 trial experience Robert Adam Mitchell 68

Moderator(s): TBD
  • Clinical Trials - Why they are important, what to consider and how to design
    Søren Bentzen
    University of Maryland School of Medicine Baltimore, Maryland, USA
Proffered papers:
Time Title Name Abstract
14:20 MR-image-guided adaptive interventional radiotherapy boost for vaginal recurrences Valentina Lancellota 49
14:30 Adaptive MRI-guided Stereotactic Body Radiation Therapy for pancreatic cancer: Clinical outcomes in a prospective cohort Pia Hartfelt 11
14:40 MR-guided ultra-hypofractionated radiotherapy with real-time motion management for early-stage glottic cancer patients Sabine Linden 83
14:50 Clinical Outcomes of MRI-guided Pelvic Reirradiation in Previously Irradiated Locally Recurrent Rectal Cancer Angela Romano 65

Moderator(s): TBD
  • AI for radiation therapy
    Lorenzo Placidi
    Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Proffered papers:
Time Title Name Abstract
15:40 From motion to dose: Dosimetric evaluation of motion-based margins using AI-predicted dose in MR-Linac adaptive workflows Nina Tilly 97
15:50 Catching MRI outliers: unsupervised detection and localization of MRI artefacts and clinical anomalies using deep learning Musti Kadhim 5
16:00 Eliminating synthetic CT? Fast AI dose calculation directly on MRI Nikolaos Delopoulos 17
16:10 AI-based organ segmentation to streamline MRI-guided adaptive radiotherapy for locally advanced pancreatic cancer Elisabeth Kildegaard 23
16:20 Predictors of Treatment Plan Adaptation in Radiation Therapy for Pancreatic Cancer Anil Sethi 103

Moderator: TBD
Time Title Name Abstract
16:45 AI-empowered Four-dimensional Magnetic Resonance Fingerprinting (AIE-4DMRF) for Accurate and Efficient Liver Cancer Radiotherapy Motion Management Chenyang LIU 44
16:55 Repeatability coefficient thresholding for voxelwise qMRI treatment response in head and neck cancer Ryan Bonate 86
17:05 Microstructural Assessment of Oral Squamous Cell Carcinoma Using Time-Dependent Diffusion MRI Jamila Guichelaar 24
17:15 Diffusion-MRI hypoxia mapping with distortion correction in head and neck cancer radiotherapy Minoo Gandomi 13
17:25 Motion-Corrected Multimodality MRF for Pseudo-CT Generation: A Feasibility Study in Abdominal Radiotherapy Yimin Ni 7
17:35 Low cost, high reward: real-time motion management for pancreatic tumors on the 1.5 T MR-Linac Bloem van Dam 15
17:45 Multi-contrast conditional organs-at-risk segmentation for online adaptive MR-guided radiotherapy of pancreatic cancer Mehdi Shojaei 98

Tuesday, 18th of June

Moderator(s): TBD
  • The current evidence and future directions for MRI biomarkers in radiation therapy
    Lars Olsson
    Lund University , Lund, Sweden
Moderator: TBD
Time Title Name Abstract
08:55 Mathematical modeling of MRI-based tumor habitats during radiotherapy in a murine model of glioma Ayesha Das 4
09:05 Multi-institutional in-vivo characterization of consensus measurement methods for T1 and T2 mapping on the 1.5T Unity MR-linac Erik van der Bijl 54
09:15 Evaluation of the Combined Effects of Magnetic Field and Radiotherapy on Patient-Derived Pancreatic Ductal Adenocarcinoma Organoids Carlo Guglielmo Cattaneo 30
09:25 Longitudinal ADC changes on a 0.35 T MR-Linac during rectal cancer MRI-guided radiotherapy Matteo Nardini 66

Moderator(s): TBD
  • TBD
Moderator: TBD
Time Title Name Abstract
10:15 Prognostic value of diffusion-weighted MRI and clinical parameters in prediction of overall survival after SBRT in patients with pancreatic cancer Anne Bisgaard 25
10:25 Spatiotemporal Deep Learning for Early Prediction of Glioblastoma Response Using 1.5T MR-Linac Imaging Edoardo Salmeri 14
10:35 Multiparametric MRI–Based Habitat Imaging for Risk Stratification and Survival Prediction in Head and Neck Tumors Walid Dandachly 20
10:45 Prospective study on response assessment during MR-guided RT for glioblastoma – first results from the MARGA-I-study Lena Kretzschmar 39
10:55 Development and validation of MRI biomarkers of liver function radiation response for functional-guided liver SBRT Sirisha Tadimalla 79

Moderator(s): TBD
  • Basics of MRI and motion management
    Jie Deng
    UT Southwestern Medical Center, Dallas, USA
Moderator: TBD
Time Title Name Abstract
11:45 Toward augmented reality-driven, MR-guided interstitial brachytherapy with active tracking Eric Paulson 88
11:55 4D motion propagation from orthogonal cine MRI for time-resolved volumetric imaging in MR-guided radiotherapy Yuqing Xiong 72
12:05 GUIDING-U trial: Effect of audio-visual breathing guidance on improving scan efficiency for respiratory-correlated abdominal and thoracic MRI Frédérique van Gameren 67
12:15 Comparison of pilot tone- and self-navigated stack-of-stars 4D-MRI Nikolai Mickevicius 90
12:25 Feasibility of ADC-based intrafraction biological target tracking for MR-guided radiotherapy Eric Paulson 101
12:35 More Contrast, Less artifacts: Redefining cine MRI for abdominal and esophageal treatments in the MR-Linac workflow Lieke Meijers 52

Moderator: TBD
Time Title Name Abstract
13:45 Long-term efficacy and safety of ablative single-fraction stereotactic MR-guided adaptive radiotherapy from the multi-center phase 2 SMART ONE trial Michael Chuong 51
13:55 Magnetic resonance response–driven adaptive radiotherapy for locally advanced rectal cancer: long-term results of the THUNDER-2 trial (NCT04815694) Angela Romano 53
14:05 MR-Linac–based treatment of oligorecurrent prostate cancer: patient characteristics and treatment patterns from the international MOMENTUM study Kristine Skovly Nielsen 78
14:15 Radio-chemotherapy and MR-Image Guided Interventional Radiotherapy in vaginal carcinoma: a monocentric experience Valentina Lancellotta 50

Moderator(s): TBD
  • Leveraging institutional MRI expertise for radiotherapy
    Trina Herbert
    The Royal Marsden NHS Foundation Trust, London, UK
  • National safety initiatives
    TBD
  • National MRI QA network (Nimbus)
    TBD
  • A Virtual MR-linac Center: Equal Access, Shared Innovation and Expertise
    Mette Felter
  • Panel Discussion (15.45 - 16.00)

Moderator(s): TBD
  • MRI contrast mechanism, safety and novel agents
    Jan Henrik Ardenkjær
    Technical University of Denmark, Kgs Lyngby, Denmark

Moderator(s): TBD
  • Elekta (16.45 - 16.55)
  • Siemens (16.55 - 17.05)
  • Bracco (17.05 - 17.15)

Moderator: TBD
Time Title Name Abstract
17:30 Maintaining Image Quality with Less Gadolinium: Implementation of Vueway in Radiotherapy MRI Protocols Elisabeth Kildegaard 59
17:33 REPAIR-Lung: REPeAted mrI-guided stereotactic body Radiotherapy (reSBRT) for lung oligometastases, a mono-institutional retrospective analysis Giulia Panza 58
17:36 Hypoxia imaging in prostate cancer with innovative methods: the HYPOXIM clinical trial Erin Wang 34
17:39 Early ctDNA dynamics impact in locally advanced rectal cancer: interim analysis of the MOREOVER study Carlo Guglielmo Cattaneo 35
17:42 MRI guided adaptive stereotactic radiotherapy for endometrical cancer: feasibility Erik van der Bijl 77
17:45 Feasibility of online 4D-MRI within five minutes for MR-guided adaptive radiotherapy Eric Paulson 99
17:48 Distance-to-contour conditioned coregistration for Pancreatic cancer RT Josiah Simeth 89
17:51 Few-Shot Adaptation for Multi-Contrast Four-Dimensional Motion Reconstruction in Abdominal MR-guided Radiotherapy Peilin Wang 42
17:54 Clinical robustness of online adaptive 1.5T MRI-guided pancreatic SBRT: Baseline vs adaptive plan quality Uffe Bernchou 12
17:57 Accounting for cropped training data for MR-linac autosegmentation using the Tversky loss Christopher Kurz 47
18:00 Enomogram to predict the rate of loco-regional control after radiochemotherapy and interventional radiotherapy in cervical cancer Valentina Lancellotta 48
18:03 Non-breathing Abdominal Organ-At-Risk Motion Dynamics Characterized Using Golden-Angle Radial Samples and Hierarchical Motion Modeling Christopher Kehayias 92
18:06 Optimization of small bowel cine-imaging for fast 3D tracking during MR-guided Radiotherapy Yulia Shcherbakova 56
18:09 Magnetic resonance elastography enables lesion-level separation of radiation necrosis and recurrent brain metastasis Jan Saip Aunan-Diop 62
18:12 Investigating the apparent diffusion coefficient as a biomarker of treatment response in pancreas tumours on an MR-Linac Peter Latimer 74
18:15 Longitudinal magnetic resonance elastography reveals post-treatment viscoelastic changes in glioblastoma Ancuta Friismose 29
18:18 Oxygen-enhanced TOLD and BOLD MRI in prostate cancer and arterial and venous blood. Chris Moore 85
18:21 Comparing local and external nnU Net segmentation models for online prostate MRgRT David Tilly 84
18:24 Longitudinal Q-space trajectory imaging in patients with prostate cancer receiving definitive radiotherapy Ivan A. Rashid 55

Friday, 19th of June

Moderator(s): TBD
  • MRI QA recommendations and practical implementation
    Joan Chick
    University College London Hospitals NHS Foundation Trust, London, UK
Moderator: TBD
Time Title Name Abstract
09:00 Towards MR-guided particle therapy: Evaluation of polymer gel for geometrical validations with online readout Stefan Dorsch 96
09:10 An Image-Based Method to Detect Missing Distortion Correction for Gradient Non-Linearities in Externally Acquired Planning MRIs Florian Putz 71
09:20 Suitability of human body donor heads for quality assurance in MR-only radiotherapy Bernd-Niklas Axer 81
09:30 Optimizing enema and bladder filling procedures for ultra-hypofractionated online MR guided adaptive prostate radiotherapy Anders Bertelsen 28
09:40 Impact of MRI triggering strategies on exhale-position image accuracy under realistic respiratory motion conditions Frédérique van Gameren 22

Moderator(s): TBD
  • How to get the most out of low field MRI systems
    Najat Salameh
    University of Aberdeen, Aberdeen, UK
Moderator: TBD
Time Title Name Abstract
10:30 Accuracy of accelerated T1 and T2 relaxometry sequences and repeatability in pelvic tissues Julian van Oorschodt 18
10:40 Acquisition optimization for reliable quantitative MRF in MR-guided radiotherapy Xiang Wang 41
10:50 Feasibility of high b-value diffusion-weighted imaging on an MRI-linac to improve prostate lesion conspicuity Damien McHugh 75
11:00 Overcoming Low-Field Limitations in Quantitative Brain DCE-MRI Using Protocol Optimization and Probabilistic Model Selection Hassan Bagher-Ebadian 26
11:10 Technical Validation of Accelerated Diffusion-weighted MRI on a 1.5T MR-Linac Prashant Prabhakaran Nair 76
11:20 Correcting slice profile and B1 imperfections to improve the accuracy of MR fingerprinting T1 and T2 mapping on a 1.5 T MR-Linac Magali Nuixe 57

Location

The symposium will take place at Odense Concert Hall - Comwell H.C. Andersen in Odense, Denmark.

Claus Bergs Gade 9, 5000 Odense, Denmark

Odense

Located on the island of Funen (Fyn in Danish), Odense sits in the heart of Denmark. Access is straightforward via Copenhagen, Billund, or Hamburg airports, with direct rail and bus links to the city. Urban mobility is seamless with a modern light rail, free inner-city buses, and plentiful bikes. Sustainability comes standard with eco-certified hotels.
For more information go to visitodense.com

Suggested Hotels

We have a number of rooms reserved for the MRinRT symposium at Comwell/ODEON,
please use booking code: BC-OUHJUNI2026 or click on Comwell/ODEON below.

Comwell/ODEON

0.1 km from the venue

Nattergalen

0.3 km from the venue

Ansgar

0.9 km from the venue

Plaza

0.8 km from the venue

Windsor

0.7 km from the venue

Cabinn

0.5 km from the venue

Sponsors

Platinum

Registration

See the details for registering to the MRinRT symposium

Organizing Committee

Conference Chairs

Faisal Mahmood

Professor, Medical Physicist, Head of physics research
Research Unit for Oncology, Department of Clinical Research, University of Southern Denmark & Laboratory of Radiation Physics, Department of Oncology, Odense University Hospital

Tine Schytte

Professor, Consultant, Head of Radiotherapy Unit
Research Unit for Oncology, Department of Clinical Research, University of Southern Denmark & Department of Oncology, Odense University Hospital

MRinRT 2026 Team

Christina Junker Nyborg

Christina Junker Nyborg

Consultant, Head of Department
Department of Oncology,
Odense University Hospital

Anni Young Lundgaard

Anni Young Lundgaard

Consultant
Department of Oncology,
Odense University Hospital

Anders Smedegaard Bertelsen

Anders Smedegaard Bertelsen

Medical Physicist
Laboratory of Radiation Physics,
Department of Oncology,
Odense University Hospital

Uffe Bernchou

Uffe Bernchou

Associate Professor, Medical Physicist
Research Unit for Oncology,
Department of Clinical Research,
University of Southern Denmark &
Laboratory of Radiation Physics,
Department of Oncology,
Odense University Hospital

Administration Support

Emilie Helgesen Karlsson

PhD Student, IT support
Laboratory of Radiation Physics,
Department of Oncology,
Odense University Hospital